Cargando…

I-19 Neuromuscular electrical stimulation training in facio-scapulo-humeral muscular dystrophy

Detalles Bibliográficos
Autor principal:	Sacconi, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore SpA 2011
Materias:	Lectures by Invited Speakers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235828/

Ejemplares similares

Intermittent Pre-Excitation-Syndrome in Facio-Scapulo-Humeral Muscular Dystrophy
por: Finsterer, Josef, et al.
Publicado: (2014)

Facio-scapulo-humeral muscular dystrophy with early joint contractures and rigid spine
por: PAPADOPOULOS, CONSTANTINOS, et al.
Publicado: (2019)

Atypical onset in a series of 122 cases with FacioScapuloHumeral Muscular Dystrophy
por: Pastorello, Ebe, et al.
Publicado: (2012)

Facio-scapulo-humeral muscular dystrophy and its connection with facio-scapuloperoneal muscular dystrophy 4q35-linked: some historical remarks
Publicado: (2014)

I-18 Chronic muscle electrical stimulation in Myotonic Dystrophy
por: Chisari, C.
Publicado: (2011)

I-23 Respiratory rehabilitation in Duchenne Muscular Dystrophy
por: Fiorentino, G., et al.
Publicado: (2011)

I-21 Current therapeutic guidelines in Duchenne Muscular Dystrophy to prolong life
por: Riccio, V., et al.
Publicado: (2011)

I-6 Pharmacological strategies for Muscular Dystrophies. Review of the literature and personal data
por: Politano, L.
Publicado: (2011)

Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD)
por: Ansseau, Eugénie, et al.
Publicado: (2017)

I-22 Early indicators of respiratory impairment in muscular dystrophies: from bioengineering to rehabilitation
por: D'Angelo, M.G.
Publicado: (2011)

P-6 Unusual concurrence of Facio-scapulo-humeral dystrophy and Williams Syndrome in a young boy
por: Cecio, M.R., et al.
Publicado: (2011)

Assessment of diaphragm motion using ultrasonography in a patient with facio-scapulo-humeral dystrophy: A case report
por: Fayssoil, Abdallah, et al.
Publicado: (2019)

The D4Z4 Macrosatellite Repeat Acts as a CTCF and A-Type Lamins-Dependent Insulator in Facio-Scapulo-Humeral Dystrophy
por: Ottaviani, Alexandre, et al.
Publicado: (2009)

I-17 Functional evaluation of muscle impairment in neuromuscular disorders
por: Mazzone, E.
Publicado: (2011)

Segregation between SMCHD1 mutation, D4Z4 hypomethylation and Facio-Scapulo-Humeral Dystrophy: a case report
por: Gaillard, Marie-Cécile, et al.
Publicado: (2016)

Analysis of the 4q35 chromatin organization reveals distinct long-range interactions in patients affected with Facio-Scapulo-Humeral Dystrophy
por: Gaillard, Marie-Cécile, et al.
Publicado: (2019)

I-8 Muscle maturation and early pathogenic findings in spinal muscular atrophy: any clues for therapy?
por: Tizzano, E.
Publicado: (2011)

On the Nomenclature of Scapulo-Humeral Dislocations
por: Bell, Joseph
Publicado: (1863)

Amputation in the Scapulo-Humeral Articulation
por: Minas, P. A.
Publicado: (1873)

A Case of Muscular Dystrophy, Scapulo-Humoral Type
por: Cullen, J. P.
Publicado: (1925)

I-12 Timothy Syndrome and Cardiomyopathy
por: Bloise, R.
Publicado: (2011)

I-20 Wearable monitoring systems and rehabilitation
por: De Rossi, D.
Publicado: (2011)

I-11 News in non dystrophic myotonias
por: Deymeer, F.
Publicado: (2011)

I-3 Treatment of CPT2 deficiency with bezafibrate
por: Laforet, P.
Publicado: (2011)

I-5 Emerging treatment strategies in mitochondrial disorders
por: Mancuso, M.
Publicado: (2011)

I-1 History of Myology in Italy and its international collections
por: Angelini, C.
Publicado: (2011)

I-13 Muscle ryanodine receptor in congenital myopathies and channelopathies
por: Treves, S., et al.
Publicado: (2011)

I-10 Pathogenesis of muscle degeneration in periodic paralyses and DMD
por: Lehmann-Horn, F., et al.
Publicado: (2011)

I-15 Neuromyotonia: Potassium channelopathy or non ionic disease?
por: Serratrice, G.
Publicado: (2011)

I-9 Opportunities and challenges of pharmaceutical research and development today
por: Middleton, L.
Publicado: (2011)

I-7 Autoimmune Inflammatory Myopathies: Summary on Pathogenesis and Therapies
por: Dalakas, M.
Publicado: (2011)

I-2 Can we bypass a muscle metabolic defect?
por: Argov, Z.
Publicado: (2011)

I-16 Crossing barriers: how medical doctors and researchers can partner with Advocacy Groups
por: Feld, L.
Publicado: (2011)

I-14 Molecular pathomechanism of DM2/PROMM: similarities and differences between DM1 and DM2
por: Meola, G.
Publicado: (2011)

I-4 Long-term follow-up effects on enzyme replacement treatment of adult form of acid maltase deficiency myopathy
por: Angelini, C., et al.
Publicado: (2011)

Lighting a candle in the dark: advances in the genetics and (gene) therapy of retinal dystrophies
por: den Hollander, Anneke I
Publicado: (2012)

Emery‐Dreifuss muscular dystrophy
por: Heller, Scott A., et al.
Publicado: (2019)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4v6eg9lqhve6r5967kbhnnugbq